Catheter Precision appoints Philip Anderson as CFO, grants 500K stock options

Catheter Precision, Inc.

Philip Anderson appointed CFO effective Jan 6, 2025, replacing interim CFO Margrit Thomassen who becomes Controller.
Compensation: $200k base salary, discretionary bonus, and option grant of 500,000 shares at $0.53, vesting monthly over 3 years.
Anderson previously CFO at Heritage Distilling, Crown Electrokinetics, Kubient; retired from Nov 2022 to Dec 2024.
Stock options issued under Section 4(a)(2) as inducement to accept employment; no family or discloseable relationships.

item 3.02 item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Philip Anderson

Chief Financial Officer

VTAK · Catheter Precision, Inc.

Effective: 2025-01-06
Filed: January 7, 2025, 6:59 PM ET

On January 4, 2025, the Board of Directors of Catheter Precision, Inc. (the “Company”) appointed Philip Anderson as Chief Financial Officer of the Company, effective January 6, 2025.

Role change

Margrit Thomassen

Interim Chief Financial Officer

VTAK · Catheter Precision, Inc.

Effective: 2025-01-06
Successor: Philip Anderson
Filed: January 7, 2025, 6:59 PM ET

Ms. Margrit Thomassen, the Company’s previous Interim Chief Financial Officer, ceased serving in that capacity on January 6, 2025 and will continue in the role of Company Controller.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Philip Anderson was appointed as Chief Financial Officer at Catheter Precision, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On January 4, 2025, the Board of Directors of Catheter Precision, Inc. (the “Company”) appointed Philip Anderson as Chief Financial Officer of the Company, effective January 6, 2025.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Margrit Thomassen changed role as Interim Chief Financial Officer at Catheter Precision, Inc..

Action: ceased serving
Role: Interim Chief Financial Officer

Exact text from the filing

Ms. Margrit Thomassen, the Company’s previous Interim Chief Financial Officer, ceased serving in that capacity on January 6, 2025 and will continue in the role of Company Controller.

View on SEC.gov

Catheter Precision, Inc. filing history →

Source: SEC EDGAR

accession 0001654954-25-000174

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.